Angiotensin II-induced increase in slowly exchanging 45Ca2+ in relation to contractile responses of rat and guinea-pig aorta

  • P. M. M. van Heiningen
  • H. D. Batink
  • P. A. van Zwieten


To gain more information about sources of activator Ca2+ involved in the contraction of rat and guinea-pig aorta evoked by angiotensin II and their sensitivity to Ca 2+ entry blockers, measurement of slowly exchanging 45Ca2+ was established. A more physiological procedure was used, replacing La3+- and EGTA- containing solutions by a normal Ca2+-containing buffer. It was demonstrated that the angiotensin 11-induced increase in slowly exchanging 45Ca2+ in rat aorta was incompletely (by approximately 60%–70%) inhibited by the organic Ca2+ entry blockers nifedipine, verapamil and diltiazem and by other Ca+ entry blocking compounds like CoCl2 and chlorpromazine. 8-(N,N-diethylamino)octyl 3,4,5-trimethoxybenzoate hydrochloride (TMB-8) was able to inhibit the angiotensin II-induced increase in 45Ca2+ content completely, but this may be an intracellular storage effects. By contrast, the organic Ca2+ entry blockers completely inhibited that part of the angiotensin II-induced contraction of rat aorta which was dependent upon extracellular Ca2+.

In guinea-pig aorta, the increase in 45Ca2+ content elicited by angiotensin 11 could be completely suppressed by all compounds under study. The results of these experiments correlated well with data from the functional experiments in guinea-pig aorta. In both preparations the release of Ca 2+ from a rapidly as well as a slowly exchanging intracellular pool appears to contribute to the contractile response elicited by angiotensin 11.

Key words

45Ca2+ Angiotensin II Calcium entry blockers Rat aorta Guinea-pig aorta 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Akaike N, Brown AM, Nishi K, Tsuda Y (1981) Actions of verapamil, diltiazem and other divalent cations on the calcium-current of Helix neurones. Br J Pharmacol 74:87–95Google Scholar
  2. Bolton TB (1979) Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev 59:606–718Google Scholar
  3. Cauvin C, Loutzenhiser R, van Breemen C (1983) Mechanisms of calcium antagonist-induced vasodilation. Annu Rev Pharmacol Toxicol 23:373–396Google Scholar
  4. Chiou CY, Malagodi MH (1975) Studies on the mechanism of action of a new Ca 2+ antagonist, 8-(N,N-diethylamino)octyl 3,4,5-trimethoxybenzoate hydrochloride in smooth and skeletal muscles. Br J Pharmacol 53:279–285Google Scholar
  5. Dacquet C, Mironneau C, Mironneau J (1987) Effects of calcium entry blockers on calcium-dependent contractions of rat portal vein. Br J Pharmacol 92:203–211Google Scholar
  6. Elliot ME, Alexander RC, Goodfriend TL (1982) Aspects of angiotensin action in the adrenal. Key roles for calcium and phosphatidyl inositol. Hypertension 4 [Suppl II]:52–58Google Scholar
  7. Flaim SF, Brannan MD, Swigart SC, Gleason MM, Muschek LD (1985) Neuroleptic drugs attenuate calcium influx and tension development in rabbit thoracic aorta: Effects of pimozide, penfluridol, chlorpromazine, and haloperidol. Proc Natl Acad Sci USA 82:1237 -1241Google Scholar
  8. Freer RJ (1975) Calcium and angiotensin tachyphylaxis in rat uterine smooth muscle. Am J Physiol 228:1423–1430Google Scholar
  9. Godfraind T (1976) Calcium exchange in vascular smooth muscle, action of noradrenaline and lanthanum. J Physiol (Lond) 260:21–35Google Scholar
  10. Godfraind T, Miller RC (1983) Specificity of action of Ca2+ entry blockers. A comparison of their actions in rat arteries and in human coronary arteries. Circ Res 52 [Suppl I]:81–91Google Scholar
  11. Gould RJ, Murphy KMM, Snyder SH (1982) Nitrendipine-labelled calcium channels discriminate inorganic calcium agonists and antagonists. Proc Natl Acad Sci USA 79:3656–3660Google Scholar
  12. Gouw MAM (1989) Further evidence for noradrenaline-induced Ca++ influx in the isolated guinea-pig aorta which is insensitive to nifedipine. Ph.D.-Thesis, University of Amsterdam, pp 79–85Google Scholar
  13. Gouw MAM, Wilffert B, van Zwieten PA (1989) Effects of calcium entry blocking agents on 5-hydroxytryptamine- and noradrenaline-induced contractions of rat isolated jugular vein and aorta. Naunyn Schmiedebergs Arch Pharmacol 339:533–539Google Scholar
  14. Hof RP (1984) The calcium antagonists PY 108–068 and verapamil diminish the effects of angiotensin II: Sites of interaction in the peripheral circulation of anaesthetized cats. Br J Pharmacol 82:51–60Google Scholar
  15. Hurwitz L (1986) Pharmacology of calcium channels and smooth muscle. Annu Rev Pharmacol Toxicol 26:225–258Google Scholar
  16. Hwang KS, van Breemen C (1985) Effects of the Ca agonist Bay K8644 on 45Ca influx and net Ca uptake into rabbit aortic smooth muscle. Fed Proc 44:P459Google Scholar
  17. Khalil R, Lodge N, Saida K, van Breemen C (1987) Mechanism of calcium activation in vascular smooth muscle. J Hypertens 5 [Suppl 4]:S5-S15Google Scholar
  18. Koch P, Wilhelm D, Wermelskirchen D, Nebel U, Wilffert B, Peters T (1988) Different effects of R56865 and calcium entry blockers on K+- and noradrenaline-induced contractions and 45Ca uptake in rat aorta. Eur J Pharmacol 158:183–190Google Scholar
  19. Kojima I, Kojima K, Rasmussen H (1985) Mechanism of inhibitory action of TMB-8 [8-(NN-diethylamino)octyl-3,4,5-trimethoxybenzoate] on aldosterone secretion in adrenal glomerulosa cells. Biochem J232:87–92Google Scholar
  20. Kühn M, Safayhi H, Ammon HPT (1988) Effects of the calmodulin antagonists W7 and CGS 9343B on cytosolic free calcium in RINm 5 F insulinoma cells. Naunyn Schmiedebergs Arch Pharmacol 337 [Suppl]:R 56Google Scholar
  21. Lippton HL, Armstead WM, Hyman AL, Kadowitz PJ (1987) Influence of calcium-entry blockade on vasoconstrictor responses in feline mesenteric vascular bed. Circ Res 61:570–580Google Scholar
  22. Loutzenhiser R, Leyten P, Saida K, van Breemen C (1985) Calcium compartments and mobilization during contraction of smooth muscle. In: Grover AK, Daniel EE (eds) Calcium and contractility. Smooth muscle. Humana Press, Clifton, New Jersey, pp 61–92Google Scholar
  23. Lüllmann H, Ziegler A (1987a) Role of calcium in the activation of smooth muscle. J Hypertens 5 [Suppl 4]:S 17-S 19Google Scholar
  24. Lüllmann H, Ziegler A (1987b) Critical remarks on the Ca-flux determinations in smooth and cardiac muscle. J Cardiovasc Pharmacol 10 [Suppl 1]:S49-S52Google Scholar
  25. Meisheri KD, Palmer RF, van Breemen C (1980) The effects of amrinone on contractility, Ca2+ uptake and cAMP in smooth muscle. Eur J Pharmacol 61:159–165Google Scholar
  26. Ogawa N, Kushida H, Satoh S (1984) Effect of verapamil on renal vasoconstriction induced by angiotensin II, norepinephrine or renal nerve stimulation in anesthetized dogs. Arch Int Pharmacodyn Ther 268:113 -121Google Scholar
  27. Prozialeck WC, Weiss B (1982) Inhibition of calmodulin by phenothiazines and related drugs: structure-activity relationships. J Pharmacol Exp Ther222:509–516Google Scholar
  28. Sanchez A, Hallam TJ, Rink TJ (1983) Trifluoperazine and chlorpromazine block secretion from human platelets evoked at basal cytoplasmic free calcium by activators of C-kinase. FEBS Lett 164:43–46Google Scholar
  29. Schleiffer R, Gairard A (1985) Angiotensin II enhances calcium exchanges in isolated rat aorta. Eur J Pharmacol 111:129–132Google Scholar
  30. Shibata S, Carrier O Jr, Frankenheim J (1968) Effect of chlorpromazine, dibenamine and phenoxybenzamine on the contractile response of taenia coli to potassium, acetylcholine, angiotensin and barium. J Pharmacol Exp Ther 160:106–111Google Scholar
  31. Vaghy PL, Itagaki K, Miwa K, McKenna E, Schwartz A (1988) Mechanism of action of calcium channel modulator drugs. Identification of a unique, labile, drug-binding polypeptide in a purified calcium channel preparation. In: Vanhoutte PM, Paoletti R, Govoni S (eds) Calcium antagonists. Pharmacology and clinical research. The New York Academy of Sciences, New York, pp 176–186Google Scholar
  32. van Breemen C, McNaughton E (1970) The separation of cell membrane calcium transport from extracellular calcium exchange in vascular smooth muscle. Biochem Biophys Res Commun 39:567–574Google Scholar
  33. van Breemen C, Hwang O, Siegel B (1977) The lanthanum method. In: Casteels (ed) Excitation-contraction coupling in smooth muscle. Elsevier, Amsterdam, pp 243–252Google Scholar
  34. van Heiningen PNM, van Zwieten PA (1988) Differential sensitivity to calcium entry blockade of angiotensin II-induced contractions of rat and guinea-pig aorta. Arch Int Pharmacodyn Ther 296:118–130Google Scholar
  35. Weichman BM, Muccitelli RM, Tucker SS, Wasserman MA (1983) Effect of calcium antagonists of leukotriene D4-induced contractions of the guinea-pig trachea and lung parenchyma. J Pharmacol Exp Ther 225:310–315Google Scholar
  36. Wendt-Gallitelli MF, Isenberg G (1985) Extra- and intracellular lanthanum: modified calcium distribution, inward currents and contractility in guinea pig ventricular preparations. Pflugers Arch 405:310–322Google Scholar
  37. Wermelskirchen D, Wilhelm D, Wilffert B, Pegram BL, Hunter J, Nebel U, Peters T (1988) Measurement of slowly exchanging 45Ca in rat aorta without using EGTA or lanthanum and its application to quantify the effects of the calcium entry blockers nifedipine and verapamil. Pharmacology 36:84–90Google Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • P. M. M. van Heiningen
    • 1
    • 2
  • H. D. Batink
    • 2
  • P. A. van Zwieten
    • 1
  1. 1.Pharma Bio-Research Int. B. V.ZuidlarenThe Netherlands
  2. 2.Division of PharmacotherapyUniversity of Amsterdam, Academic Medical CentreAmsterdamThe Netherlands

Personalised recommendations